#Islam #Muslim #Quran #Faith #Belief #Believe #Trust #Truth #Allah #Lord #One #Oath #Messenger #Prophet #Muhammad #Liar #Dispute #Yemen #Possession #Witness

#Islam #Muslim #Quran #Faith #Belief #Believe #Trust #Truth #Allah #Lord #One #Oath #Messenger #Prophet #Muhammad #Liar #Dispute #Yemen #Possession #Witness

Online Clothing Rental Market Size, Industry Analysis It is estimated for the global online clothing rental market to witness growth at a CAGR of 9.1% during the forecast period of 2022 to 2030. https://wemarketresearch.com/reports/online-clothing-rental-market/722

Chocolate Market Size, Industry Analysis Report It is estimated for the global chocolate market to witness growth at a CAGR of 4.1% during the forecast period of 2022 to 2030. https://wemarketresearch.com/reports/chocolate-market/728

Green Cement Market Size, Industry Analysis Report It is estimated for the global green cement market to witness growth at a CAGR of 12.5% during the forecast period of 2022 to 2030. The market witnessed growth at a CAGR of 9.8% during the previous forecast period of 2018 to 2021. https://wemarketresearch.com/reports/green-cement-market/806

Unleash the Therapeutic Potential of Music at Santosh Ghatpande's Music Therapy in Pune. Whether you're coping with stress, anxiety, or striving for emotional equilibrium, our customized sessions provide a distinctive path to holistic wellness. Led by a skilled specialist, you'll witness the profound influence of music on improving your mental well-being. Visit us in Pune to discover how music can revolutionize your life. Reserve your session now and begin a quest towards inner tranquility and balance. https://www.santoshghatpande.com/counsellor-in-pune

Probiotics Market Size, Demand, Analytical Overview, Comprehensive Analysis, Segmentation, Competitive Landscape 2035 Probiotics Market: Market Landscape The global probiotics market size is estimated to be $70.9 billion in 2024 and is projected to reach $165.1 billion by 2035. The market is anticipated to grow at a CAGR of 8.0%, during the forecast period till 2035. The current market landscape features over 95 key probiotic companies that are engaged in offering probiotics. Several key companies (established as well as start-ups) in the probiotic domain offer various types of products, including probiotic foods, beverages, dietary supplements and infant formula. Notable examples of mid-sized probiotic companies based in Europe (in alphabetical order) include AB-BIOTICS, BioGaia, Enzymedica, Myprotein, PetLab and Zinereo Pharma. Interestingly, the end users of probiotic industry are children, infants, humans and animals. Various types of novel strains are being studied by the industry in order to identify its usage as a probiotic. These formulations can be used in foods, beverages, formulaes and supplements. Most of the key probiotic companies were established pre-2000, depticting that the probiotics industry consists of some well-established players that have a strong customer base. Some examples of such probiotic companies include (in alphabetical order) adisseo, Bharat Biotech, Danone, IFF, Morinaga Milk, NowFoods, Tata, Yakult Honsha and Zipvit. Majority of the key players (75%) offer probiotic dietary supplements; of these, more than 90% companies offer both nutritional as well as specialty supplements that support specific health conditions, such as mental, oral, bone, immune and women health. Apart from offering various types of probiotics for the human population, the key probiotic companies are also extensively engaged in offering probiotics for infants and children, whose microbiome is different and thus require different combinations of strains in the probiotic products. More than 500 patents related to probiotics have been filed / granted by the probiotic providers in order to protect the intellectual property generated within this field. Over the past decade, industry stakeholders have been extensively working towards the development of novel probiotic formulations and products. Recently, the domain has witnessed significant advancements, both in terms of introduction of novel probiotics to support overall well-being and specific health conditions. As a result, a number of patents have been filed / granted to protect the new intellectual capital generated by the probiotic companies engaged in offering various types of probiotics. During our research, it was observed that majority of the patents filed by probiotic companies in this domain are patent applications (73.6%), followed by those which have been granted approval (26%). Further, majority of the patents (39%) were filed / granted in North America, followed by Asia Pacific (27%). Moreover, despite the large number of patents that have been filed by probiotic companies recently (and hence having a long remaining patent life), only 2% of the total patents have the highest relative valuation. Using our proprietary methodology, we have provided informed projections, describing the likely growth of the opportunity associated with the probiotics market. As per the base case forecast scenario, the probiotic market size is estimated to grow at a CAGR of 8.0%, during the forecast period. The market growth of this industry is believed to be primarily driven by the numerous advantages offered by probiotics for prevention and treatment of diseases. This is anticipated to sustain the demand for various types of probiotics, resulting in lucrative monetization opportunities for probiotic companies. It is worth mentioning that according to our projections, Asia Pacific is likely to capture the majority (more than 45%) of the overall market share, and this trend is unlikely to change in the future, as well. It is worth highlighting that the global market in Latin America is expected to grow at a relatively healthy CAGR, during the forecast period. Further, it is worth mentioning that, as per the probiotics market segmentation, probiotic dietary supplements segment in the probiotics market is anticipated to grow at a higher CAGR, during the forecast period. Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs. To view more details on this report, click on the link https://www.rootsanalysis.com/reports/probiotics-market.html

RNA Therapeutics Market Report by Worldwide Market Trends & Opportunities and Forecast to 2035 Owing to their clinical potential to specifically target and treat various disease indications, the next generation RNA therapeutics and vaccines have gained significant traction and are anticipated to revolutionize the healthcare and medical sector. The global RNA therapeutics and vaccines market size is estimated to grow from USD 1.2 million in 2023 to USD 948 million by 2035, representing a CAGR of 68% during the forecast period 2023-2035. Over the years, RNA-based therapeutics and vaccines have been studied extensively for their crucial role in gene function and protein expression regulation. Owing to their vast potential in the treatment of a myriad of disease indications, targeting previously deemed undruggable targets, and high therapeutic efficiency, these molecules have transitioned into a compelling treatment alternative for a range of disorders. However, a major challenge in the implementation of these therapies lies in the highly unstable structure of the RNA molecule. The loose prime terminals of RNA molecules allow quick degradation of these molecules by restriction exonucleases. In recent years, the advent of advanced technologies and platforms has escalated the interest of industry stakeholders towards enhanced and modified RNA-based therapies, that are believed to be highly stable and have an extended impact at relatively low doses. The types of next generation RNA therapeutics and RNA vaccines include circular RNA (circRNA), endless RNA (eRNA), self activating RNA (sacRNA), self amplifying RNA (saRNA), self amplifying mRNA (samRNA), replicating RNA (repRNA) and transfer RNA (tRNA). The success of these next generation RNA therapeutics and RNA vaccines can be attributed to their structural stability, expression specificity, targeted delivery, non-immunogenic nature, high efficiency and ability to target a wide range of therapeutic modalities, including influenza, COVID-19 infection, breast cancer and interstitial lung disease, among others. Next generation RNA therapeutics and RNA vaccines offer great promise in the healthcare sector, as a result of which, various drug and technology developers are shifting their focus towards the design, development, manufacturing and delivery of these innovative modalities. Given the ongoing pace of innovation in this field, encouraging clinical trial results, accelerated approvals, and the continuous efforts of both industry and non-industry players, the next generation RNA vaccines and RNA therapeutics market is likely to witness significant growth during the forecast period. Over 35 next generation RNA technologies are being developed / offered by companies for the research, discovery, design, development, manufacturing and delivery of novel rna therapies and vaccines. Currently, over 35 next generation RNA technologies are being developed / offered by industry players. It is worth mentioning that most of the technologies are being deployed for next generation RNA based therapeutics. Examples of technologies used in the development of both self-amplifying RNA therapeutics and vaccines include ChaESAR Technology and VaxEquity’s Next-generation RNA Platform. The number and geographical distribution of clinical trials are important indicators of both the therapeutic viability and future potential of innovative pharmacological interventions. Over the years, several pharmaceutical / biopharmaceutical companies have conducted extensive clinical studies for only those drug / therapy classes that are likely to translate into commercial success. Moreover, the geographical distribution directly indicates the various markets that are open to receiving / adopting the intervention under investigation. As more product candidates get approved by the regulatory authorities across the globe, the number of clinical trials across different global regions is anticipated to increase. There was a steady increase in the number of clinical trials registered for the evaluation of next generation RNA therapeutics and vaccines, during the period 2019-2023. This increase can be attributed to the incessant efforts of several industry / non-industry players that are actively developing and testing different types of novel RNA-based approaches for the treatment of a wide range of disorders. It is also worth highlighting that, over the years, most of the trials (33%) were registered in 2022. Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs. To view more details on this report, click on the link https://www.rootsanalysis.com/reports/rna-therapeutics-market.html

Tugboat super 12000 puffs The world of vaping has witnessed a significant shift towards disposable vapes, and the ELF BAR BC10000 Puffs has taken the industry by storm. With its impressive features and benefits. vape shop. ae has become a favorite among vapers. https://vapshop.ae/product/tugboat-super-12000puffs-disposable-vape/

In recent years, India has witnessed a significant shift in how society perceives topics surrounding sexual wellness. The discussion of sex toys in India has moved from being a hush-hush subject to a topic of interest among people seeking enhanced intimacy, self-discovery, and improved relationships. While the stigma remains in certain segments, the growing awareness about sexual health and the availability of high-quality products have led to a burgeoning market for sex toys across the country. https://trykartehai.com/ https://trykartehai.com/ https://trykartehai.com/ https://trykartehai.com/